88R12086 JSC-D
 
  By: Moody, Dutton, Geren, Anchía, Cain, H.B. No. 218
      et al.
 
  Substitute the following for H.B. No. 218:
 
  By:  Moody C.S.H.B. No. 218
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the criminal and licensing consequences of certain
  offenses relating to the possession of marihuana, certain
  tetrahydrocannabinols, certain synthetic cannabinoids, and drug
  paraphernalia; imposing a fee.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Article 14.06, Code of Criminal Procedure, is
  amended by adding Subsections (b-1) and (b-2) and amending
  Subsection (d) to read as follows:
         (b-1)  A peace officer who is charging a person with
  committing an offense under Section 481.1161(b)(1), 481.121(b)(1),
  or 481.125(a), Health and Safety Code, may not arrest the person and
  shall issue the person a citation as provided by Subsection (b).
         (b-2)  Subsection (b-1) does not apply to an officer making
  an arrest for an offense other than an offense under Section
  481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and Safety
  Code.
         (d)  Subsection (c) applies only to a person charged with
  committing an offense under:
               (1)  Section 481.121, Health and Safety Code, if the
  offense is punishable under Subsection (b)(1-a) [(b)(1)] or (2) of
  that section;
               (1-a)  Section 481.1161, Health and Safety Code, if the
  offense is punishable under Subsection (b)(1-a) [(b)(1)] or (2) of
  that section;
               (2)  Section 28.03, Penal Code, if the offense is
  punishable under Subsection (b)(2) of that section;
               (3)  Section 28.08, Penal Code, if the offense is
  punishable under Subsection (b)(2) or (3) of that section;
               (4)  Section 31.03, Penal Code, if the offense is
  punishable under Subsection (e)(2)(A) of that section;
               (5)  Section 31.04, Penal Code, if the offense is
  punishable under Subsection (e)(2) of that section;
               (6)  Section 38.114, Penal Code, if the offense is
  punishable as a Class B misdemeanor; or
               (7)  Section 521.457, Transportation Code.
         SECTION 2.  Subchapter B, Chapter 45, Code of Criminal
  Procedure, is amended by adding Article 45.02161 to read as
  follows:
         Art. 45.02161.  EXPUNCTION OF CERTAIN RECORDS. (a) This
  article applies only to a person charged with an offense under
  Section 481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and
  Safety Code.
         (b)  Records of a person relating to a complaint may be
  expunged under this article if:
               (1)  the complaint was dismissed under Article 45.051
  or 45.052 or other law and:
                     (A)  at least 180 days have elapsed from the date
  of the dismissal; or
                     (B)  at least one year has elapsed from the date of
  the citation; or
               (2)  the person was acquitted of the offense.
         (c)  The person must make a written request to have the
  records expunged. The request must be under oath.
         (d)  The court shall order all complaints, verdicts,
  sentences, and prosecutorial and law enforcement records and any
  other documents relating to the offense expunged from the person's
  record if the court finds that the person satisfies the
  requirements of this article.
         (e)  The justice or municipal court shall require a person
  who requests expungement under this article to pay a fee in the
  amount of $30 to defray the cost of notifying state agencies of
  orders of expungement under this article.
         (f)  The procedures for expunction provided under this
  article are separate and distinct from the expunction procedures
  under Chapter 55.
         SECTION 3.  Article 45.051, Code of Criminal Procedure, is
  amended by adding Subsections (a-2) and (e-1) to read as follows:
         (a-2)  Unless the defendant has previously received a
  deferral of disposition for an offense under Section
  481.1161(b)(1), 481.121(b)(1), or 481.125(a), Health and Safety
  Code, committed within the 12-month period preceding the date of
  the commission of the instant offense, on plea of guilty or nolo
  contendere for either offense, the judge shall defer further
  proceedings without entering an adjudication of guilt and place the
  defendant on probation under the provisions of this article.
         (e-1)  A court that dismisses a complaint under this article
  for a person charged with an offense under Section 481.1161(b)(1),
  481.121(b)(1), or 481.125(a), Health and Safety Code, shall notify
  the defendant in writing of the person's expunction rights under
  Article 45.02161 and provide the person with a copy of that article.
  The dismissed complaint is not a conviction and may not be used
  against the person for any purpose.
         SECTION 4.  Section 411.0728(a), Government Code, is amended
  to read as follows:
         (a)  This section applies only to a person:
               (1)  who is convicted of or placed on deferred
  adjudication community supervision for an offense under:
                     (A)  Section 481.1161, Health and Safety Code, if
  the offense is punishable under Subsection (b)(1-a);
                     (B)  Section 481.120, Health and Safety Code, if
  the offense is punishable under Subsection (b)(1);
                     (C) [(B)]  Section 481.121, Health and Safety
  Code, if the offense is punishable under Subsection (b)(1-a) 
  [(b)(1)];
                     (D) [(C)]  Section 31.03, Penal Code, if the
  offense is punishable under Subsection (e)(1) or (2); or
                     (E) [(D)]  Section 43.02, Penal Code; and
               (2)  who, if requested by the applicable law
  enforcement agency or prosecuting attorney to provide assistance in
  the investigation or prosecution of an offense under Section
  20A.02, 20A.03, or 43.05, Penal Code, or a federal offense
  containing elements that are substantially similar to the elements
  of an offense under any of those sections:
                     (A)  provided assistance in the investigation or
  prosecution of the offense; or
                     (B)  did not provide assistance in the
  investigation or prosecution of the offense due to the person's age
  or a physical or mental disability resulting from being a victim of
  an offense described by this subdivision.
         SECTION 5.  Sections 481.002(5) and (6), Health and Safety
  Code, are amended to read as follows:
               (5)  "Controlled substance" means a substance,
  including a drug, an adulterant, and a dilutant, listed in
  Schedules I through V or Penalty Group 1, 1-A, 1-B, 2, 2-A, 2-B, 3,
  or 4. The term includes the aggregate weight of any mixture,
  solution, or other substance containing a controlled substance.
  The term does not include hemp, as defined by Section 121.001,
  Agriculture Code, or the tetrahydrocannabinols in hemp.
               (6)  "Controlled substance analogue" means:
                     (A)  a substance with a chemical structure
  substantially similar to the chemical structure of a controlled
  substance in Schedule I or II or Penalty Group 1, 1-A, 1-B, 2, [or]
  2-A, or 2-B; or
                     (B)  a substance specifically designed to produce
  an effect substantially similar to, or greater than, the effect of a
  controlled substance in Schedule I or II or Penalty Group 1, 1-A,
  1-B, 2, [or] 2-A, or 2-B.
         SECTION 6.  Section 481.103(a), Health and Safety Code, is
  amended to read as follows:
         (a)  Penalty Group 2 consists of:
               (1)  any quantity of the following hallucinogenic
  substances, their salts, isomers, and salts of isomers, unless
  specifically excepted, if the existence of these salts, isomers,
  and salts of isomers is possible within the specific chemical
  designation:
                     5-(2-aminopropyl)benzofuran (5-APB);
                     6-(2-aminopropyl)benzofuran (6-APB);
                     5-(2-aminopropyl)-2,3-dihydrobenzofuran
  (5-APDB);
                     6-(2-aminopropyl)-2,3-dihydrobenzofuran
  (6-APDB);
                     5-(2-aminopropyl)indole (5-IT,5-API);
                     6-(2-aminopropyl)indole (6-IT,6-API);
                     1-(benzofuran-5-yl)-N-methylpropan-2-amine
  (5-MAPB);
                     1-(benzofuran-6-yl)-N-methylpropan-2-amine
  (6-MAPB);
                     Benzothiophenylcyclohexylpiperidine (BTCP);
                     8-bromo-alpha-methyl-benzo[1,2-b:4,5-b']difuran-
  4-ethanamine (trade or other name: Bromo-DragonFLY);
                     Desoxypipradrol (2-benzhydrylpiperidine);
                     2, 5-dimethoxyamphetamine (some trade or other
  names:  2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
                     Diphenylprolinol (diphenyl(pyrrolidin-2-yl)
  methanol, D2PM);
                     Dronabinol (synthetic) in sesame oil and
  encapsulated in a soft gelatin capsule in a U.S. Food and Drug
  Administration approved drug product (some trade or other names for
  Dronabinol:  (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
  trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
  (trans)- tetrahydrocannabinol);
                     Ethylamine Analog of Phencyclidine (some trade or
  other names:  N-ethyl-1-phenylcyclohexylamine, (1-
  phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
  cyclohexamine, PCE);
                     2-ethylamino-2-(3-methoxyphenyl)cyclohexanone
  (trade or other name: methoxetamine);
                     Ibogaine (some trade or other names:  7-Ethyl-6,
  6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
  pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
                     5-iodo-2-aminoindane (5-IAI);
                     Mescaline;
                     5-methoxy-3, 4-methylenedioxy amphetamine;
                     4-methoxyamphetamine (some trade or other
  names:  4-methoxy-alpha-methylphenethylamine;
  paramethoxyamphetamine; PMA);
                     4-methoxymethamphetamine (PMMA);
                     2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone
  (some trade and other names: 2-MeO-ketamine; methoxyketamine);
                     1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
  PPMP);
                     4-methyl-2, 5-dimethoxyamphetamine (some trade
  and other names:  4-methyl-2, 5-dimethoxy-alpha-
  methylphenethylamine; "DOM"; "STP");
                     3,4-methylenedioxy methamphetamine (MDMA, MDM);
                     3,4-methylenedioxy amphetamine;
                     3,4-methylenedioxy N-ethylamphetamine (Also
  known as N-ethyl MDA);
                     5,6-methylenedioxy-2-aminoindane (MDAI);
                     Nabilone (Another name for nabilone:  (+)-trans-
  3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
  6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
                     N-benzylpiperazine (some trade or other
  names:  BZP; 1-benzylpiperazine);
                     N-ethyl-3-piperidyl benzilate;
                     N-hydroxy-3,4-methylenedioxyamphetamine (Also
  known as N-hydroxy MDA);
                     4-methylaminorex;
                     N-methyl-3-piperidyl benzilate;
                     Parahexyl (some trade or other names:  3-Hexyl-1-
  hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
  pyran; Synhexyl);
                     1-Phenylcyclohexylamine;
                     1-Piperidinocyclohexanecarbonitrile (PCC);
                     Pyrrolidine Analog of Phencyclidine (some trade
  or other names:  1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
                     [Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure and
  pharmacological activity such as:
                           [delta-1 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           [delta-6 cis or trans tetrahydrocannabinol,
  and their optical isomers;
                           [delta-3, 4 cis or trans
  tetrahydrocannabinol, and its optical isomers; or
                           [compounds of these structures, regardless
  of numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized;]
                     Thiophene Analog of Phencyclidine (some trade or
  other names:  1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
  Analog of Phencyclidine; TPCP, TCP);
                     1-pyrrolidine (some trade or other name:  TCPy);
                     1-(3-trifluoromethylphenyl)piperazine (trade or
  other name:  TFMPP); and
                     3,4,5-trimethoxy amphetamine;
               (2)  Phenylacetone (some trade or other
  names:  Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
  ketone);
               (3)  unless specifically excepted or unless listed in
  another Penalty Group, a material, compound, mixture, or
  preparation that contains any quantity of the following substances
  having a potential for abuse associated with a depressant or
  stimulant effect on the central nervous system:
                     Aminorex (some trade or other
  names:  aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
  phenyl-2-oxazolamine);
                     Amphetamine, its salts, optical isomers, and
  salts of optical isomers;
                     Cathinone (some trade or other names:  2-amino-1-
  phenyl-1-propanone, alpha-aminopropiophenone, 2-
  aminopropiophenone);
                     Etaqualone and its salts;
                     Etorphine Hydrochloride;
                     Fenethylline and its salts;
                     Lisdexamfetamine, including its salts, isomers,
  and salts of isomers;
                     Mecloqualone and its salts;
                     Methaqualone and its salts;
                     Methcathinone (some trade or other names:  2-
  methylamino-propiophenone; alpha-(methylamino)propriophenone;
  2-(methylamino)-1-phenylpropan-1-one; alpha-N-
  methylaminopropriophenone; monomethylpropion; ephedrone, N-
  methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
  1431);
                     N-Ethylamphetamine, its salts, optical isomers,
  and salts of optical isomers; and
                     N,N-dimethylamphetamine (some trade or other
  names: N,N,alpha-trimethylbenzeneethanamine;
  N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
  and salts of optical isomers;
               (4)  any compound structurally derived from
  2-aminopropanal by substitution at the 1-position with any
  monocyclic or fused-polycyclic ring system, including:
                     (A)  compounds further modified by:
                           (i)  substitution in the ring system to any
  extent (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or
  halide substituents), whether or not further substituted in the
  ring system by other substituents;
                           (ii)  substitution at the 3-position with an
  alkyl substituent; or
                           (iii)  substitution at the 2-amino nitrogen
  atom with alkyl, benzyl, dialkyl, or methoxybenzyl groups, or
  inclusion of the 2-amino nitrogen atom in a cyclic structure; and
                     (B)  by example, compounds such as:
                           4-Methylmethcathinone (Also known as
  Mephedrone);
                           3,4-Dimethylmethcathinone (Also known as
  3,4-DMMC);
                           3-Fluoromethcathinone (Also known as 3-FMC);
                           4-Fluoromethcathinone (Also known as
  Flephedrone);
                           3,4-Methylenedioxy-N-methylcathinone (Also
  known as Methylone);
                           3,4-Methylenedioxypyrovalerone (Also known
  as MDPV);
                           alpha-Pyrrolidinopentiophenone (Also known
  as alpha-PVP);
                           Naphthylpyrovalerone  (Also known as
  Naphyrone);
                           alpha-Methylamino-valerophenone (Also known
  as Pentedrone);
                           beta-Keto-N-methylbenzodioxolylpropylamine
  (Also known as Butylone);
                           beta-Keto-N-methylbenzodioxolylpentanamine
  (Also known as Pentylone);
                           beta-Keto-Ethylbenzodioxolylbutanamine
  (Also known as Eutylone); and
                           3,4-methylenedioxy-N-ethylcathinone (Also
  known as Ethylone);
               (5)  any compound structurally derived from tryptamine
  (3-(2-aminoethyl)indole) or a ring-hydroxy tryptamine:
                     (A)  by modification in any of the following ways:
                           (i)  by substitution at the amine nitrogen
  atom of the sidechain to any extent with alkyl or alkenyl groups or
  by inclusion of the amine nitrogen atom of the side chain (and no
  other atoms of the side chain) in a cyclic structure;
                           (ii)  by substitution at the carbon atom
  adjacent to the nitrogen atom of the side chain (alpha-position)
  with an alkyl or alkenyl group;
                           (iii)  by substitution in the 6-membered
  ring to any extent with alkyl, alkoxy, haloalkyl, thioaklyl,
  alkylenedioxy, or halide substituents; or
                           (iv)  by substitution at the 2-position of
  the tryptamine ring system with an alkyl substituent; and
                     (B)  including:
                           (i)  ethers and esters of the controlled
  substances listed in this subdivision; and
                           (ii)  by example, compounds such as:
                                 alpha-ethyltryptamine;
                                 alpha-methyltryptamine;
                                 Bufotenine (some trade and other names:
  3-(beta-Dimethylaminoethyl)-5-hydroxyindole;
  3-(2-dimethylaminoethyl)- 5- indolol; N, N-dimethylserotonin;
  5-hydroxy-N, N- dimethyltryptamine; mappine);
                                 Diethyltryptamine (some trade and
  other names: N, N-Diethyltryptamine, DET);
                                 Dimethyltryptamine (trade or other
  name: DMT);
                                 5-methoxy-N, N-diisopropyltryptamine
  (5-MeO-DiPT);
                                 O-Acetylpsilocin (Trade or other name:
  4-Aco-DMT);
                                 Psilocin; and
                                 Psilocybin;
               (6)  2,5-Dimethoxyphenethylamine and any compound
  structurally derived from 2,5-Dimethoxyphenethylamine by
  substitution at the 4-position of the phenyl ring to any extent
  (including alkyl, alkoxy, alkylenedioxy, haloalkyl, or halide
  substituents), including, by example, compounds such as:
                     4-Bromo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-B);
                     4-Chloro-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-C);
                     2,5-Dimethoxy-4-methylphenethylamine (trade or
  other name: 2C-D);
                     4-Ethyl-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-E);
                     4-Iodo-2,5-dimethoxyphenethylamine (trade or
  other name: 2C-I);
                     2,5-Dimethoxy-4-nitrophenethylamine (trade or
  other name: 2C-N);
                     2,5-Dimethoxy-4-(n)-propylphenethylamine (trade
  or other name: 2C-P);
                     4-Ethylthio-2,5-dimethoxyphenethylamine (trade
  or other name: 2C-T-2);
                     4-Isopropylthio-2,5-dimethoxyphenethylamine
  (trade or other name: 2C-T-4); and
                     2,5-Dimethoxy-4-(n)-propylthiophenethylamine
  (trade or other name:  2C-T-7); and
               (7)  2,5-Dimethoxyamphetamine and any compound
  structurally derived from 2,5-Dimethoxyamphetamine by substitution
  at the 4-position of the phenyl ring to any extent (including alkyl,
  alkoxy, alkylenedioxy, haloalkyl, or halide substituents),
  including, by example, compounds such as:
                     4-Ethylthio-2,5-dimethoxyamphetamine (trade or
  other name: Aleph-2);
                     4-Isopropylthio-2,5-dimethoxyamphetamine (trade
  or other name: Aleph-4);
                     4-Bromo-2,5-dimethoxyamphetamine (trade or other
  name: DOB);
                     4-Chloro-2,5-dimethoxyamphetamine (trade or
  other name: DOC);
                     2,5-Dimethoxy-4-ethylamphetamine (trade or other
  name: DOET);
                     4-Iodo-2,5-dimethoxyamphetamine (trade or other
  name: DOI);
                     2,5-Dimethoxy-4-methylamphetamine (trade or
  other name: DOM);
                     2,5-Dimethoxy-4-nitroamphetamine (trade or other
  name: DON);
                     4-Isopropyl-2,5-dimethoxyamphetamine (trade or
  other name: DOIP); and
                     2,5-Dimethoxy-4-(n)-propylamphetamine (trade or
  other name: DOPR).
         SECTION 7.  Subchapter D, Chapter 481, Health and Safety
  Code, is amended by adding Section 481.1032 to read as follows:
         Sec. 481.1032.  PENALTY GROUP 2-B. (a) Penalty Group 2-B
  consists of any quantity of the following substances, their salts,
  isomers, and salts of isomers, unless specifically excepted, if the
  existence of these salts, isomers, and salts of isomers is possible
  within the specific chemical designation:
               Tetrahydrocannabinols, other than marihuana, and
  synthetic equivalents of the substances contained in the plant, or
  in the resinous extractives of Cannabis, or synthetic substances,
  derivatives, and their isomers with similar chemical structure and
  pharmacological activity such as:
                     delta-1 cis or trans tetrahydrocannabinol, and
  their optical isomers;
                     delta-6 cis or trans tetrahydrocannabinol, and
  their optical isomers;
                     delta-3, 4 cis or trans tetrahydrocannabinol, and
  their optical isomers; or
                     compounds of these structures, regardless of
  numerical designation of atomic positions, since nomenclature of
  these substances is not internationally standardized.
         (b)  For the purposes of this section, the term "isomer"
  includes an optical, position, or geometric isomer.
         SECTION 8.  Section 481.106, Health and Safety Code, is
  amended to read as follows:
         Sec. 481.106.  CLASSIFICATION OF CONTROLLED SUBSTANCE
  ANALOGUE. For the purposes of the prosecution of an offense under
  this subchapter involving the manufacture, delivery, or possession
  of a controlled substance, Penalty Groups 1, 1-A, 1-B, 2, [and] 2-A,
  and 2-B include a controlled substance analogue that:
               (1)  has a chemical structure substantially similar to
  the chemical structure of a controlled substance listed in the
  applicable penalty group; or
               (2)  is specifically designed to produce an effect
  substantially similar to, or greater than, a controlled substance
  listed in the applicable penalty group.
         SECTION 9.  The heading to Section 481.113, Health and
  Safety Code, is amended to read as follows:
         Sec. 481.113.  OFFENSE: MANUFACTURE OR DELIVERY OF SUBSTANCE
  IN PENALTY GROUP 2, [OR] 2-A, OR 2-B.
         SECTION 10.  Section 481.113(a), Health and Safety Code, is
  amended to read as follows:
         (a)  Except as authorized by this chapter, a person commits
  an offense if the person knowingly manufactures, delivers, or
  possesses with intent to deliver a controlled substance listed in
  Penalty Group 2, [or] 2-A, or 2-B.
         SECTION 11.  Section 481.115(h), Health and Safety Code, is
  amended to read as follows:
         (h)  The defense to prosecution provided by Subsection (g) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.1151(b)(1),
  481.116(b), 481.1161(b)(1), (1-a), or (2), 481.117(b), 481.118(b),
  or 481.121(b)(1), (1-a), or (2), or an offense under Section
  481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.1151(c), 481.116(f), 481.1161(c),
  481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to the possible
  overdose of the actor or another person.
         SECTION 12.  Section 481.1151(d), Health and Safety Code, is
  amended to read as follows:
         (d)  The defense to prosecution provided by Subsection (c) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.116(b), 481.1161(b)(1), (1-a), or (2), 481.117(b), 481.118(b),
  or 481.121(b)(1), (1-a), or (2), or an offense under Section
  481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.116(f), 481.1161(c),
  481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 13.  Section 481.116(g), Health and Safety Code, is
  amended to read as follows:
         (g)  The defense to prosecution provided by Subsection (f) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.1161(b)(1), (1-a), or (2), 481.117(b),
  481.118(b), or 481.121(b)(1), (1-a), or (2), or an offense under
  Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.1161(c),
  481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 14.  The heading to Section 481.1161, Health and
  Safety Code, is amended to read as follows:
         Sec. 481.1161.  OFFENSE: POSSESSION OF SUBSTANCE IN PENALTY
  GROUP 2-A OR 2-B.
         SECTION 15.  Sections 481.1161(a), (b), (c), and (d), Health
  and Safety Code, are amended to read as follows:
         (a)  Except as authorized by this chapter, a person commits
  an offense if the person knowingly possesses a controlled substance
  listed in Penalty Group 2-A or 2-B, unless the person obtained the
  substance directly from or under a valid prescription or order of a
  practitioner acting in the course of professional practice.
         (b)  An offense under this section is:
               (1)  a Class C misdemeanor if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, one ounce or less;
               (1-a)  a Class B misdemeanor if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, two ounces or less but more than one
  ounce;
               (2)  a Class A misdemeanor if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, four ounces or less but more than two
  ounces;
               (3)  a state jail felony if the amount of the controlled
  substance possessed is, by aggregate weight, including adulterants
  or dilutants, five pounds or less but more than four ounces;
               (4)  a felony of the third degree if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, 50 pounds or less but more than 5 pounds;
               (5)  a felony of the second degree if the amount of the
  controlled substance possessed is, by aggregate weight, including
  adulterants or dilutants, 2,000 pounds or less but more than 50
  pounds; and
               (6)  punishable by imprisonment in the Texas Department
  of Criminal Justice for life or for a term of not more than 99 years
  or less than 5 years, and a fine not to exceed $50,000, if the amount
  of the controlled substance possessed is, by aggregate weight,
  including adulterants or dilutants, more than 2,000 pounds.
         (c)  It is a defense to prosecution for an offense punishable
  under Subsection (b)(1), (1-a), or (2) that the actor:
               (1)  was the first person to request emergency medical
  assistance in response to the possible overdose of another person
  and:
                     (A)  made the request for medical assistance
  during an ongoing medical emergency;
                     (B)  remained on the scene until the medical
  assistance arrived; and
                     (C)  cooperated with medical assistance and law
  enforcement personnel; or
               (2)  was the victim of a possible overdose for which
  emergency medical assistance was requested, by the actor or by
  another person, during an ongoing medical emergency.
         (d)  The defense to prosecution provided by Subsection (c) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.117(b), 481.118(b), or
  481.121(b)(1), (1-a), or (2), or an offense under Section
  481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.117(f), 481.118(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during  the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 16.  Section 481.117(g), Health and Safety Code, is
  amended to read as follows:
         (g)  The defense to prosecution provided by Subsection (f) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.118(b), or 481.121(b)(1), (1-a), or (2), or an offense under
  Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.118(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 17.  Section 481.118(g), Health and Safety Code, is
  amended to read as follows:
         (g)  The defense to prosecution provided by Subsection (f) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), or 481.121(b)(1), (1-a), or (2), or an offense under
  Section 481.119(b), 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.119(c), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 18.  Section 481.119(d), Health and Safety Code, is
  amended to read as follows:
         (d)  The defense to prosecution provided by Subsection (c) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an
  offense under Section 481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.118(f), 481.121(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to
  the  possible overdose of the actor or another person.
         SECTION 19.  Sections 481.121(b), (c), and (d), Health and
  Safety Code, are amended to read as follows:
         (b)  An offense under Subsection (a) is:
               (1)  a Class C misdemeanor if the amount of marihuana
  possessed is one ounce or less;
               (1-a)  a Class B misdemeanor if the amount of marihuana
  possessed is two ounces or less but more than one ounce;
               (2)  a Class A misdemeanor if the amount of marihuana
  possessed is four ounces or less but more than two ounces;
               (3)  a state jail felony if the amount of marihuana
  possessed is five pounds or less but more than four ounces;
               (4)  a felony of the third degree if the amount of
  marihuana possessed is 50 pounds or less but more than 5 pounds;
               (5)  a felony of the second degree if the amount of
  marihuana possessed is 2,000 pounds or less but more than 50 pounds;
  and
               (6)  punishable by imprisonment in the Texas Department
  of Criminal Justice for life or for a term of not more than 99 years
  or less than 5 years, and a fine not to exceed $50,000, if the amount
  of marihuana possessed is more than 2,000 pounds.
         (c)  It is a defense to prosecution for an offense punishable
  under Subsection (b)(1), (1-a), or (2) that the actor:
               (1)  was the first person to request emergency medical
  assistance in response to the possible overdose of another person
  and:
                     (A)  made the request for medical assistance
  during an ongoing medical emergency;
                     (B)  remained on the scene until the medical
  assistance arrived; and
                     (C)  cooperated with medical assistance and law
  enforcement personnel; or
               (2)  was the victim of a possible overdose for which
  emergency medical assistance was requested, by the actor or by
  another person, during an ongoing medical emergency.
         (d)  The defense to prosecution provided by Subsection (c) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), or 481.118(b), or an offense under Section 481.119(b),
  481.125(a), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.125(g),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to the possible
  overdose of the actor or another person.
         SECTION 20.  Section 481.122(a), Health and Safety Code, is
  amended to read as follows:
         (a)  A person commits an offense if the person knowingly
  delivers a controlled substance listed in Penalty Group 1, 1-A,
  1-B, 2, 2-A, 2-B, or 3 or knowingly delivers marihuana and the
  person delivers the controlled substance or marihuana to a person:
               (1)  who is a child;
               (2)  who is enrolled in a public or private primary or
  secondary school; or
               (3)  who the actor knows or believes intends to deliver
  the controlled substance or marihuana to a person described by
  Subdivision (1) or (2).
         SECTION 21.  Section 481.124(d), Health and Safety Code, is
  amended to read as follows:
         (d)  An offense under this section is:
               (1)  a felony of the second degree if the controlled
  substance is listed in Penalty Group 1, 1-A, or 1-B;
               (2)  a felony of the third degree if the controlled
  substance is listed in Penalty Group 2, 2-A, or 2-B;
               (3)  a state jail felony if the controlled substance is
  listed in Penalty Group 3 or 4; or
               (4)  a Class A misdemeanor if the controlled substance
  is listed in a schedule by an action of the commissioner under this
  chapter but not listed in a penalty group.
         SECTION 22.  Section 481.125(h), Health and Safety Code, is
  amended to read as follows:
         (h)  The defense to prosecution provided by Subsection (g) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an
  offense under Section 481.119(b), 483.041(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 483 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),
  483.041(e), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to the possible
  overdose of the actor or another person.
         SECTION 23.  Section 481.134(f), Health and Safety Code, is
  amended to read as follows:
         (f)  An offense otherwise punishable under Section
  481.1161(b)(1-a), 481.118(b), 481.119(b), 481.120(b)(1), or
  481.121(b)(1-a) [481.121(b)(1)] is a Class A misdemeanor if it is
  shown on the trial of the offense that the offense was committed:
               (1)  in, on, or within 1,000 feet of any real property
  that is owned, rented, or leased to a school or school board, the
  premises of a public or private youth center, or a playground;
               (2)  on a school bus; or
               (3)  by any unauthorized person 18 years of age or
  older, in, on, or within 1,000 feet of premises owned, rented, or
  leased by a general residential operation operating as a
  residential treatment center.
         SECTION 24.  Section 483.041(f), Health and Safety Code, is
  amended to read as follows:
         (f)  The defense to prosecution provided by Subsection (e) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an
  offense under Section 481.119(b), 481.125(a), or 485.031(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 481 or 485;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),
  481.125(g), or 485.031(c); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to the possible
  overdose of the actor or another person.
         SECTION 25.  Section 485.031(d), Health and Safety Code, is
  amended to read as follows:
         (d)  The defense to prosecution provided by Subsection (c) is
  not available if:
               (1)  at the time the request for emergency medical
  assistance was made:
                     (A)  a peace officer was in the process of
  arresting the actor or executing a search warrant describing the
  actor or the place from which the request for medical assistance was
  made; or
                     (B)  the actor is committing another offense,
  other than an offense punishable under Section 481.115(b),
  481.1151(b)(1), 481.116(b), 481.1161(b)(1), (1-a), or (2),
  481.117(b), 481.118(b), or 481.121(b)(1), (1-a), or (2), or an
  offense under Section 481.119(b), 481.125(a), or 483.041(a);
               (2)  the actor has been previously convicted of or
  placed on deferred adjudication community supervision for an
  offense under this chapter or Chapter 481 or 483;
               (3)  the actor was acquitted in a previous proceeding
  in which the actor successfully established the defense under that
  subsection or Section 481.115(g), 481.1151(c), 481.116(f),
  481.1161(c), 481.117(f), 481.118(f), 481.119(c), 481.121(c),
  481.125(g), or 483.041(e); or
               (4)  at any time during the 18-month period preceding
  the date of the commission of the instant offense, the actor
  requested emergency medical assistance in response to the possible
  overdose of the actor or another person.
         SECTION 26.  Sections 551.003(11) and (12), Occupations
  Code, are amended to read as follows:
               (11)  "Controlled substance" means a substance,
  including a drug:
                     (A)  listed in Schedule I, II, III, IV, or V, as
  established by the commissioner of public health under Chapter 481,
  Health and Safety Code, or in Penalty Group 1, 1-A, 1-B, 2, 2-A,
  2-B, 3, or 4, Chapter 481; or
                     (B)  included in Schedule I, II, III, IV, or V of
  the Comprehensive Drug Abuse Prevention and Control Act of 1970 (21
  U.S.C. Section 801 et seq.).
               (12)  "Dangerous drug" means a drug or device that:
                     (A)  is not included in Penalty Group 1, 1-B, 2,
  2-A, 2-B, 3, or 4, Chapter 481, Health and Safety Code, and is
  unsafe for self-medication; or
                     (B)  bears or is required to bear the legend:
                           (i)  "Caution: federal law prohibits
  dispensing without prescription" or "Rx only" or another legend
  that complies with federal law; or
                           (ii)  "Caution: federal law restricts this
  drug to use by or on the order of a licensed veterinarian."
         SECTION 27.  Section 521.371(3), Transportation Code, is
  amended to read as follows:
               (3)  "Drug offense" has the meaning assigned under 23
  U.S.C. Section 159(c) and includes an offense under Section 49.04,
  49.07, or 49.08, Penal Code, that is committed as a result of the
  introduction into the body of any substance the possession of which
  is prohibited under the Controlled Substances Act. The term does
  not include an offense punishable by fine only under the laws of
  this state.
         SECTION 28.  The changes in law made by this Act apply only
  to an offense committed on or after the effective date of this Act.
  An offense committed before the effective date of this Act is
  governed by the law in effect on the date the offense was committed,
  and the former law is continued in effect for that purpose. For
  purposes of this section, an offense was committed before the
  effective date of this Act if any element of the offense was
  committed before that date.
         SECTION 29.  (a) Except as otherwise provided by this
  section, this Act takes effect September 1, 2023.
         (b)  Section 521.371, Transportation Code, as amended by
  this Act, takes effect on the 91st day after the date the office of
  the attorney general publishes in the Texas Register a finding
  that:
               (1)  the legislature of this state has adopted a
  resolution expressing the legislature's opposition to a law meeting
  the requirements of 23 U.S.C. Section 159 in suspending, revoking,
  or denying the driver's license of a person convicted of a drug
  offense punishable by fine only for a period of six months;
               (2)  the governor of this state has submitted to the
  United States secretary of transportation:
                     (A)  a written certification of the governor's
  opposition to the enactment or enforcement of a law required under
  23 U.S.C. Section 159 as that law relates to offenses punishable by
  fine only; and
                     (B)  a written certification that the legislature
  has adopted the resolution described by Subdivision (1) of this
  subsection; and
               (3)  the United States secretary of transportation has
  responded to the governor's submission and certified that highway
  funds will not be withheld from this state in response to the
  modification or full or partial repeal of the law required under 23
  U.S.C. Section 159.